Axsome 制药 AXSM
$132.37 +$2.57 (+1.98%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $132.37 0.00%
开盘$130.46
昨收$129.80
当日区间$130.00 – $133.79
成交量718.4K
市值$6.96B
市盈率（TTM）–
股息率–
AXSM 相关新闻
匹配 Axsome Therapeutics 或代码 AXSM 的头条新闻，按最新排序。
- Deutsche Bank Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Cuts Target Price to $267 负面
- Morgan Stanley Maintains Axsome Therapeutics(AXSM.US) With Hold Rating, Maintains Target Price $251
- H.C. Wainwright Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $290
- Truist Financial Initiates Axsome Therapeutics(AXSM.US) With Buy Rating, Announces Target Price $285
- H.C. Wainwright Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)
- Piper Sandler Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $258
- RBC Capital Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $297
- BMO Capital Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $310
- Mizuho Securities Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $316
- Mizuho Securities Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $306
- Mizuho Securities Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Raises Target Price to $316 正面
- Jefferies Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $380
- A Quick Look at Today's Ratings for Axsome Therapeutics(AXSM.US), With a Forecast Between $251 to $315
- RBC Capital Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Cuts Target Price to $297 负面
- Mizuho Securities Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Cuts Target Price to $306 负面
暂无评论——快来第一个聊聊 AXSM。
登录后参与讨论。